BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 31391072)

  • 1. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
    Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW
    Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model.
    Stankevicins L; Barat A; Dessen P; Vassetzky Y; de Moura Gallo CV
    PLoS One; 2017; 12(3):e0173756. PubMed ID: 28346474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
    Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
    BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.
    Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ
    J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
    Zhao C; Ling X; Li X; Hou X; Zhao D
    Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
    Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
    PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
    Lee J; Kim HE; Song YS; Cho EY; Lee A
    Breast Cancer Res Treat; 2019 Jul; 176(1):119-130. PubMed ID: 30989460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human 21T breast epithelial cell lines mimic breast cancer progression in vivo and in vitro and show stage-specific gene expression patterns.
    Souter LH; Andrews JD; Zhang G; Cook AC; Postenka CO; Al-Katib W; Leong HS; Rodenhiser DI; Chambers AF; Tuck AB
    Lab Invest; 2010 Aug; 90(8):1247-58. PubMed ID: 20458274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
    Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
    Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
    Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
    J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF; Li YC; Wang Y; Sun LB
    Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer.
    Ma N; Zhang W; Qiao C; Luo H; Zhang X; Liu D; Zang S; Zhang L; Bai J
    Cell Physiol Biochem; 2016; 38(4):1435-46. PubMed ID: 27035590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP.
    Pu T; Shen M; Li S; Yang L; Gao H; Xiao L; Zhong X; Zheng H; Liu Y; Ye F; Bu H
    Lab Invest; 2019 Sep; 99(9):1296-1308. PubMed ID: 31024042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-205-5p Downregulation and
    Kalinkova L; Nikolaieva N; Smolkova B; Ciernikova S; Kajo K; Bella V; Kajabova VH; Kosnacova H; Minarik G; Fridrichova I
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1.
    Hou XW; Sun X; Yu Y; Zhao HM; Yang ZJ; Wang X; Cao XC
    Neoplasma; 2017; 64(4):526-534. PubMed ID: 28485158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
    Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
    Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.
    Zhang N; Zhang H; Liu Y; Su P; Zhang J; Wang X; Sun M; Chen B; Zhao W; Wang L; Wang H; Moran MS; Haffty BG; Yang Q
    Cell Death Differ; 2019 May; 26(5):843-859. PubMed ID: 29988076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.